Follow The Filings

ORKA position history

The shares of Oruka Therapeutics (ORKA) that VIKING GLOBAL INVESTORS LP reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q3: 2,666,690 shares, $51M, 0.13% of portfolio, New
  2. 2025 Q4: 2,666,690 shares, $81M, 0.21% of portfolio
  3. 2026 Q1: 2,666,690 shares, $131M, 0.37% of portfolio
  4. 2026 Q2: 1,503,478 shares, $143M, 0.41% of portfolio, Reduce −43.6%
Holdings date Value % of holdings Shares Filing date All 13F holders